Pharma-Bio Serv Q2 Revenue Jumps 11.8% to $2.7M, EPS Up 150%
Reported by Wiseek News
Sentiment
Positive
Importance
8
Price
$0.565
Mkt Cap
$12.939M
52W Low
$0.313
52W High
$1.36
Market data snapshot near publication time
Summary
Pharma-Bio Serv reported strong Q2 2026 results, with revenue climbing 11.8% year-over-year to $2.7 million and diluted EPS jumping 150% to $0.01. Net income surged 144.3% to $233K. This follows the 10-Q filing earlier today. The significant growth in profitability is driven by expansion in Puerto Rico and cost reductions from moving to virtual operations, signaling improved operational performance for the micro-cap company.
At the time of this announcement, PBSV was trading at $0.57 on OTC in the Life Sciences sector, with a market capitalization of approximately $12.9M. The 52-week trading range was $0.31 to $1.36. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.
Price Chart
PBSV - Latest Insights
PBSV
Jun 15, 2026, 4:51 PM EDT
Price at Filing:
$0.565
Real-time Price:
$0.565
Change:
$0 (0%)
Market Cap:
$12.939M
PBSV
Jun 15, 2026, 4:49 PM EDT
Price at Filing:
$0.565
Real-time Price:
$0.565
Change:
$0 (0%)
Market Cap:
$12.939M
PBSV
Apr 16, 2026, 4:15 PM EDT
Price at Filing:
$0.500
Real-time Price:
$0.565
Change:
+$0.065 (+13%)
Market Cap:
$12.939M
PBSV
Mar 17, 2026, 5:00 PM EDT
Price at Filing:
$0.480
Real-time Price:
$0.565
Change:
+$0.085 (+18%)
Market Cap:
$12.939M
PBSV
Feb 27, 2026, 4:16 PM EST
Price at Filing:
$0.490
Real-time Price:
$0.565
Change:
+$0.075 (+15%)
Market Cap:
$12.939M
PBSV
Jan 29, 2026, 5:07 PM EST
Price at Filing:
$0.54056
Real-time Price:
$0.565
Change:
+$0.02444 (+5%)
Market Cap:
$12.939M
PBSV
Jan 29, 2026, 4:49 PM EST
Price at Filing:
$0.54056
Real-time Price:
$0.565
Change:
+$0.02444 (+5%)
Market Cap:
$12.939M